Methyl aminolevulinate (Metvix)
Methyl aminolevulinate
Galderma Laboratories S.A. (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Galderma Laboratories S.A. (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Metvix cream EACH 1,0 g CREAM CONTAINS METHYL AMINOLEVULINATE 160,0 mg | Cream | A380528A38/26/0528 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Methyl 5-amino-4-oxopentanoate
Drag to rotate. Structure from PubChem CID 157922.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.